Showing results (481-490 of 1,372) with videos related to
Sort By:
Pageof 138
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2023
Establishing cognitive baseline in three generations: Framingham Heart StudyJin Yang, Ting Fang Alvin Ang, Sophia Lu, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 11, 2026
Population disparities in Alzheimer's disease: A systematic review of fluid and neuroimaging biomarkersLinus Kpelle, Ansumana Bockarie, Maxwell Hubert Antwi, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 3, 2025
Generative diffusion model enables quantification of calibration-free arterial spin labeling perfusion magnetic resonance imaging data in an Alzheimer's disease cohortQinyang Shou, Steven Cen, Nan-Kuei Chen, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 23, 2025
Genetic associations of plasma proteomics with dementia subtypes and neuroimaging markersAhmed M Salih, Janek Salatzki, Yuhe Wang, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 20, 2025
General practitioners' perspectives on blood biomarkers for Alzheimer's diseaseThomas Claessen, F C W Visser, B C van Munster, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 15, 2025
Harmonizing late-life cognitive performance data across two population-based cohort studies: The Health and Retirement Study and National Health and Aging Trends StudyDiefei Chen, Vishaldeep Kaur Sekhon, David L Roth, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 1, 2025
A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditionsAnanthan Ambikairajah, David Foxe, Ann-Marie G de Lange, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Effect of APOE ε4 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer's diseaseMohamed Raâfet Ben Khedher, Mohamed Haddad, Danielle Laurin, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Quantification of cognitive impairment to characterize heterogeneity of patients at risk of developing Alzheimer's disease dementiaDiana L Giraldo, Jan Sijbers, Eduardo Romero, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 16, 2026
Validation of the Arabic Dementia Diagnosis Attitude Scale (A-DDAS)Nibras Jasim, Eman Shatnawi, Flor Sanabria Vasquez, et al.Pageof 138